What is Mightier?
Mightier operates at the intersection of behavioral health and interactive technology. By leveraging a decade of rigorous clinical research conducted at Boston Children's Hospital and Harvard Medical School, the company has developed a proprietary system that pairs video games with biofeedback. This approach allows children to practice emotional regulation in real-time, effectively building the skills necessary to navigate complex emotional landscapes. As a leader in the digital health space, Mightier is positioned to disrupt traditional therapeutic models by providing accessible, data-driven tools that empower families and clinicians alike. The company's market position is bolstered by its ability to translate complex clinical insights into engaging, user-friendly digital experiences that drive measurable improvements in emotional strength and confidence.
How much funding has Mightier raised?
Mightier has raised a total of $26M across 3 funding rounds:
Angel/Seed
$2.4M
Series A
$6.6M
Series B
$17M
Angel/Seed (2018): $2.4M, investors not publicly disclosed
Series A (2019): $6.6M led by Foxkiser
Series B (2021): $17M supported by Sony Innovation Fund, DigiTx Partners, and PBJ Capital
Key Investors in Mightier
Sony Innovation Fund
A corporate venture arm dedicated to engaging with innovative startups to fuel the development of disruptive technologies and facilitate access to a global network.
DigiTx Partners
A venture capital firm specializing in early-stage digital health companies that leverage data analytics and personalized medicine to improve patient outcomes.
PBJ Capital
An independent venture firm focused on supporting passionate founders of disruptive technology companies with strategic capital and growth-oriented partnerships.
What's next for Mightier?
With the successful closure of its latest financing round, Mightier is well-positioned to accelerate its growth trajectory and expand its reach within the pediatric healthcare market. The strategic capital will likely be deployed to enhance the platform's technological infrastructure, broaden its clinical research initiatives, and scale its commercial operations to meet increasing demand. As the digital therapeutics industry continues to mature, Mightier's focus on evidence-based outcomes will be critical in securing long-term partnerships with healthcare providers and insurance networks. The company's ability to maintain its clinical integrity while scaling its digital footprint will be the primary driver of its future success in the competitive landscape of mental health innovation.
See full Mightier company page
